Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Covington
Merck
McKinsey
Cerilliant
Fuji
Harvard Business School
Fish and Richardson
Daiichi Sankyo

Generated: August 16, 2018

DrugPatentWatch Database Preview

Acyclovir; hydrocortisone - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for acyclovir; hydrocortisone and what is the scope of acyclovir; hydrocortisone freedom to operate?

Acyclovir; hydrocortisone is the generic ingredient in one branded drug marketed by Valeant Bermuda and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Acyclovir; hydrocortisone has fifty-seven patent family members in twenty-nine countries.

There are fifty-six drug master file entries for acyclovir; hydrocortisone. One supplier is listed for this compound.

Summary for acyclovir; hydrocortisone
International Patents:57
US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 56
Suppliers / Packagers: 1
Clinical Trials: 3
DailyMed Link:acyclovir; hydrocortisone at DailyMed

US Patents and Regulatory Information for acyclovir; hydrocortisone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Bermuda XERESE acyclovir; hydrocortisone CREAM;TOPICAL 022436-001 Jul 31, 2009 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Valeant Bermuda XERESE acyclovir; hydrocortisone CREAM;TOPICAL 022436-001 Jul 31, 2009 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for acyclovir; hydrocortisone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Bermuda XERESE acyclovir; hydrocortisone CREAM;TOPICAL 022436-001 Jul 31, 2009 ➤ Sign Up ➤ Sign Up
Valeant Bermuda XERESE acyclovir; hydrocortisone CREAM;TOPICAL 022436-001 Jul 31, 2009 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
McKesson
Chinese Patent Office
Dow
Harvard Business School
UBS
McKinsey
AstraZeneca
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.